Lnc‐TPT1‐AS1/CBP/ATIC Axis Mediated Purine Metabolism Activation Promotes Breast Cancer Progression
Open Access
- 17 March 2025
- journal article
- carcinogenesis
- Published by Wiley in Cancer Science
- Vol. 116 (6) , 1565-1578
Abstract
The purine biosynthetic pathway was recently identified to play a crucial role in breast cancer progression. However, little was known about the regulatory mechanisms of long non‐coding RNA in breast cancer purine metabolism. In this study, we discovered that LncRNA TPT1‐AS1 (TPT1‐AS1) was downregulated in breast cancer tissues. Its introduction in breast cancer cells markedly suppressed tumor growth and metastasis in xenograft tumor models. Mass spectrometric analysis suggested that the purine biosynthetic pathway was activated in TPT1‐AS1‐knockdown MCF‐7 cells. Inosine monophosphate (IMP), the product of de novo purine biosynthesis, was significantly upregulated. Mechanistically, we found that TPT1‐AS1 could physically interact with CBP (CREB‐binding protein), which consequently led to the loss of H3K27Ac in the promoter area of ATIC, the key enzyme of IMP synthesis. This process could block breast cancer purine metabolism and inhibit breast cancer progression. In conclusion, our findings illustrate the role of non‐coding RNAs in breast cancer purine metabolism reprogramming and present a potential candidate for breast cancer therapy.Keywords
Funding Information
- National Natural Science Foundation of China (82002791, 82203873)
- Natural Science Foundation of Heilongjiang Province (YQ2024H016, YQ2019H018)
This publication has 36 references indexed in Scilit:
- De novo nucleotide biosynthetic pathway and cancerGenes & Diseases, 2023
- Long non-coding RNA TPT1-AS1 sensitizes breast cancer cell to paclitaxel and inhibits cell proliferation by miR-3156-5p/caspase 2 axisHuman Cell, 2021
- Dyregulation of the lncRNA TPT1-AS1 positively regulates QKI expression and predicts a poor prognosis for patients with breast cancerPathology - Research and Practice, 2020
- Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistanceOncogene, 2019
- Dual‐Specificity Tyrosine Phosphorylation–Regulated Kinase 3 Loss Activates Purine Metabolism and Promotes Hepatocellular Carcinoma ProgressionHepatology, 2019
- Long non-coding RNA FGF13-AS1 inhibits glycolysis and stemness properties of breast cancer cells through FGF13-AS1/IGF2BPs/Myc feedback loopCancer Letters, 2019
- Purine synthesis promotes maintenance of brain tumor initiating cells in gliomaNature Neuroscience, 2017
- RNA Binding to CBP Stimulates Histone Acetylation and TranscriptionCell, 2017
- Local regulation of gene expression by lncRNA promoters, transcription and splicingNature, 2016
- Targeting Tumour Proliferation with a Small‐Molecule Inhibitor of AICAR Transformylase HomodimerizationChemBioChem, 2012